These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24989329)

  • 21. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis.
    Floreani A; Cazzagon N; Martines D; Cavalletto L; Baldo V; Chemello L
    Dig Liver Dis; 2011 Nov; 43(11):887-92. PubMed ID: 21783442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations.
    Guéchot J; Boisson RC; Zarski JP; Sturm N; Calès P; Lasnier E;
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):467-72. PubMed ID: 23932706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH.
    Kruger FC; Daniels CR; Kidd M; Swart G; Brundyn K; van Rensburg C; Kotze M
    S Afr Med J; 2011 Jun; 101(7):477-80. PubMed ID: 21920102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
    Leung DH; Khan M; Minard CG; Guffey D; Ramm LE; Clouston AD; Miller G; Lewindon PJ; Shepherd RW; Ramm GA
    Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.
    Pohl A; Behling C; Oliver D; Kilani M; Monson P; Hassanein T
    Am J Gastroenterol; 2001 Nov; 96(11):3142-6. PubMed ID: 11721762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
    Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
    Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade.
    Fujimoto K; Tonan T; Azuma S; Kage M; Nakashima O; Johkoh T; Hayabuchi N; Okuda K; Kawaguchi T; Sata M; Qayyum A
    Radiology; 2011 Mar; 258(3):739-48. PubMed ID: 21248235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.
    Taouli B; Tolia AJ; Losada M; Babb JS; Chan ES; Bannan MA; Tobias H
    AJR Am J Roentgenol; 2007 Oct; 189(4):799-806. PubMed ID: 17885048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.
    Lesmana CR; Salim S; Hasan I; Sulaiman AS; Gani RA; Pakasi LS; Lesmana LA; Krisnuhoni E; Budihusodo U
    J Clin Pathol; 2011 Oct; 64(10):916-20. PubMed ID: 21670074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging.
    Ding Y; Rao SX; Zhu T; Chen CZ; Li RC; Zeng MS
    Clin Radiol; 2015 Oct; 70(10):1096-103. PubMed ID: 26164421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
    Shaikh S; Memon MS; Ghani H; Baloch GH; Jaffery M; Shaikh K
    J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial study of biexponential model of intravoxel incoherent motion magnetic resonance imaging in evaluation of the liver fibrosis.
    Chen C; Wang B; Shi D; Fu F; Zhang J; Wen Z; Zhu S; Xu J; Lin Q; Li J; Dou S
    Chin Med J (Engl); 2014; 127(17):3082-7. PubMed ID: 25189949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravoxel incoherent motion MRI for liver fibrosis assessment: a pilot study.
    Chung SR; Lee SS; Kim N; Yu ES; Kim E; Kühn B; Kim IS
    Acta Radiol; 2015 Dec; 56(12):1428-36. PubMed ID: 25414372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis.
    Bonekamp S; Torbenson MS; Kamel IR
    J Clin Gastroenterol; 2011; 45(10):885-92. PubMed ID: 21716125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.
    Lewin M; Poujol-Robert A; Boëlle PY; Wendum D; Lasnier E; Viallon M; Guéchot J; Hoeffel C; Arrivé L; Tubiana JM; Poupon R
    Hepatology; 2007 Sep; 46(3):658-65. PubMed ID: 17663420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
    Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
    Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients.
    Lee VS; Miller FH; Omary RA; Wang Y; Ganger DR; Wang E; Rao S; Levitsky J
    Transplantation; 2011 Sep; 92(5):581-6. PubMed ID: 21822174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.